Michigan Medicine experts discuss whether active surveillance — close monitoring without immediate treatment — could reduce overtreatment for some thyroid, prostate and breast cancer patients.
Daniel Clauw, MD, Professor of Internal Medicine, Anesthesiology, and Psychiatry, and the Director of Michigan Medicine’s Chronic Pain and Fatigue Research Center, co-writes an editorial calling on primary care physicians to take a more comprehensive approach to treating patients with chronic pain.
Daniel Goldstein, MBBS, Professor of Internal Medicine and Director of the Michigan Biology of Cardiovascular Aging program, is the senior author of a new study that shows an immune cell in the lungs may help explain why.
Robert Fontana, MD, Professor of Internal Medicine and Director of Michigan Medicine’s Liver Transplant Clinic, comments on the spike in the number of reported cases of hepatitis A seen in Southeast Michigan in the past year.
A patient diagnosed with cancer received treatment and hope from her care team at the U-M Comprehensive Cancer Center, which included Anne Schott, MD, a medical oncologist in the Breast Care Center and Professor of Internal Medicine.
Richard Harris, PhD, Associate Professor of Internal Medicine and Anesthesiology, is the senior author of a new study that found patients with different chronic pain diagnoses recorded similar brain changes.
Elif Oral, MD, Associate Professor of Internal Medicine, is the author of a study that found amlexanox to be potentially helpful in treating type 2 diabetes.
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC), created by a team at Michigan Medicine and the VA Ann Arbor Healthcare System led by Vineet Chopra, MD, MSc, is now available as an app.
Charles Burant, MD, PhD, Professor of Internal Medicine, has been selected as the new director of the A. Alfred Taubman Medical Research Institute.
Lauren Wallner, PhD, MPH, Assistant Professor of Internal Medicine, is the lead author of a new study that finds half of early stage breast cancer patients relied on three or more people to help them process treatment options.
